D-0678-2017 Class III Terminated

Recalled by Novartis Pharmaceuticals Corp. — East Hanover, NJ

FDA drug recall D-0678-2017 was initiated by Novartis Pharmaceuticals Corp. on Mar 22, 2017 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications. The recall status is terminated (terminated Feb 5, 2020).

Recall details

Product Type
Drugs
Report Date
May 3, 2017
Initiation Date
Mar 22, 2017
Termination Date
Feb 5, 2020
Voluntary/Mandated
Voluntary: Firm initiated

Product description

Isopto Carpine (pilocarpine hydrochloride opthalmic solution) 4%, packaged in 15 mL bottle, Rx only, Manufactured by: Alcon Laboratories, Inc. Fort Worth Texas 76134 USA NDC 0998-0206-15

Reason for recall

Failed Impurities/Degradation Specifications.

Distribution pattern

nationwide

Code information

Lot #: 244661F, Exp. Feb 2018

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0678-2017
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0678-2017. Report a data issue: hello@regdatalab.com.